Johnson & Johnson has claimed FDA approval for Rybrevant Faspro, a subcutaneous version of its EGFRxMET bispecific antibody, for all the indications approved for the current, intravenous formulation.
A new, implantable, ultrasound-based blood pressure monitoring system represents a promising alternative to conventional tools for continuous, unobtrusive blood pressure measurement. Accurate, ...
We provide access to a range of journals, databases and other evidence-based resources for health and social care staff in England. You'll need an NHS OpenAthens account to access most of these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results